Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p295 has 46 genes in the original annotation. Currently, there are 38 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
5588	PRKCQ	PRKCT \| nPKC-theta	protein kinase C theta	10p15
5599	MAPK8	JNK \| JNK-46 \| JNK1 \| JNK1A2 \| JNK21B1/2 \| PRKM8 \| SAPK1 \| SAPK1c	mitogen-activated protein kinase 8	10q11.22
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
355	FAS	ALPS1A \| APO-1 \| APT1 \| CD95 \| FAS1 \| FASTM \| TNFRSF6	Fas cell surface death receptor	10q24.1
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
5970	RELA	NFKB3 \| p65	v-rel avian reticuloendotheliosis viral oncogene homolog A	11q13
2113	ETS1	ETS-1 \| EWSR2 \| c-ets-1 \| p54	ETS proto-oncogene 1, transcription factor	11q23.3
6667	SP1	-	Sp1 transcription factor	12q13.1
4792	NFKBIA	IKBA \| MAD-3 \| NFKBI	NFKB inhibitor alpha	14q13
5583	PRKCH	PKC-L \| PKCL \| PRKCL \| nPKC-eta	protein kinase C eta	14q23.1
2353	FOS	AP-1 \| C-FOS \| p55	FBJ murine osteosarcoma viral oncogene homolog	14q24.3
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
5579	PRKCB	PKC-beta \| PKCB \| PRKCB1 \| PRKCB2	protein kinase C beta	16p11.2
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
5606	MAP2K3	MAPKK3 \| MEK3 \| MKK3 \| PRKMK3 \| SAPKK-2 \| SAPKK2	mitogen-activated protein kinase kinase 3	17q11.2
9020	MAP3K14	FTDCR1B \| HS \| HSNIK \| NIK	mitogen-activated protein kinase kinase kinase 14	17q21
5578	PRKCA	AAG6 \| PKC-alpha \| PKCA \| PRKACA	protein kinase C alpha	17q24.2
5608	MAP2K6	MAPKK6 \| MEK6 \| MKK6 \| PRKMK6 \| SAPKK-3 \| SAPKK3	mitogen-activated protein kinase kinase 6	17q24.3
596	BCL2	Bcl-2 \| PPP1R50	B-cell CLL/lymphoma 2	18q21.3
5609	MAP2K7	JNKK2 \| MAPKK7 \| MEK \| MEK 7 \| MKK7 \| PRKMK7 \| SAPKK-4 \| SAPKK4	mitogen-activated protein kinase kinase 7	19p13.3-p13.2
1050	CEBPA	C/EBP-alpha \| CEBP	CCAAT/enhancer binding protein alpha	19q13.1
2114	ETS2	ETS2IT1	ETS proto-oncogene 2, transcription factor	21q22.2
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
5581	PRKCE	PKCE \| nPKC-epsilon	protein kinase C epsilon	2p21
5580	PRKCD	ALPS3 \| CVID9 \| MAY1 \| PKCD \| nPKC-delta	protein kinase C delta	3p21.31
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
4790	NFKB1	CVID12 \| EBP-1 \| KBF1 \| NF-kB1 \| NF-kappa-B \| NF-kappaB \| NFKB-p105 \| NFKB-p50 \| NFkappaB \| p105 \| p50	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1	4q24
1950	EGF	HOMG4 \| URG	epidermal growth factor	4q25
4214	MAP3K1	MAPKKK1 \| MEKK \| MEKK 1 \| MEKK1 \| SRXY6	mitogen-activated protein kinase kinase kinase 1	5q11.2
5515	PPP2CA	PP2Ac \| PP2CA \| PP2Calpha \| RP-C	protein phosphatase 2 catalytic subunit alpha	5q31.1
1616	DAXX	BING2 \| DAP6 \| EAP1	death-domain associated protein	6p21.3
7124	TNF	DIF \| TNF-alpha \| TNFA \| TNFSF2 \| TNLG1F	tumor necrosis factor	6p21.3
1432	MAPK14	CSBP \| CSBP1 \| CSBP2 \| CSPB1 \| EXIP \| Mxi2 \| PRKM14 \| PRKM15 \| RK \| SAPK2A \| p38 \| p38ALPHA	mitogen-activated protein kinase 14	6p21.3-p21.2
8737	RIPK1	RIP \| RIP-1 \| RIP1	receptor interacting serine/threonine kinase 1	6p25.2
4217	MAP3K5	ASK1 \| MAPKKK5 \| MEKK5	mitogen-activated protein kinase kinase kinase 5	6q22.33
1956	EGFR	ERBB \| ERBB1 \| HER1 \| NISBD2 \| PIG61 \| mENA	epidermal growth factor receptor	7p12
3551	IKBKB	IKK-beta \| IKK2 \| IKKB \| IMD15 \| NFKBIKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	8p11.2
7186	TRAF2	MGC:45012 \| TRAP \| TRAP3	TNF receptor associated factor 2	9q34